SMS Pharmaceuticals, announced that USFDA inspection to the Unit-VII located at Kandivalasa Village, Pusapatirega Mandal, Vizianagaram District in the state of Andhra Pradesh had successfully completed in the last week.
SMS Pharmaceuticals is a global player in API manufacturing having a strong research and manufacturing team supported by state of the art facilities. What started off as a single facility-single product manufacturing company in 1990 grew to be a multi-location group having product list spreading across an array of therapeutic segments.
Shares of the company gained Rs 1, or 0.19%, to trade at Rs 539. The total volume of shares traded was 3,345 at the BSE (9.57 a.m., Monday).